Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

Morgane Rolland(Henry M. Jackson Foundation), James I. Mullins(University of Washington), Julia N. Stoddard(University of Washington), Brandon S. Maust(Seattle University), Eric Sanders‐Buell, John W. Shiver(IGM Biosciences (United States)), Dana N. Raugi(Seattle University), Anne Marie O’Sullivan, Laura Heath(Seattle University), Stephanie Sorensen(University of Washington), Susan Buchbinder(University of California, San Francisco), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Craig A. Magaret(Fred Hutch Cancer Center), Nelson L. Michael(Walter Reed Army Institute of Research), Nicole Frahm(Fred Hutch Cancer Center), Steve Self(Cancer Research Center), Sheri Dubey(United States Military Academy), Jacqueline Crossler, Lawrence Corey(Fred Hutch Cancer Center), Kim Wong(University of Washington), Marty Nau, Meera Bose, Ann Duerr(Cancer Research Center), Andrea Bradfield, Wenjie Deng(University of Washington), Michael Robertson(Merck & Co., Inc., Rahway, NJ, USA (United States)), M. Juliana McElrath(Fred Hutch Cancer Center), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Fusheng Li(Guangxi University), Teresa M. Jones, Francine E. McCutchan(Bill & Melinda Gates Foundation), Hong Zhao(Seattle University), Danilo R. Casimiro(Institut Mérieux (France)), Sodsai Tovanabutra, John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jérôme H. Kim(International Vaccine Institute)
Nature Medicine
February 27, 2011
Cited by 227


Related Papers